Preservatives in glaucoma medications

Article

Preservatives are an important component of topical multidose glaucoma medications. However, many glaucoma patients have symptoms of ocular surface disease (OSD), which can affect quality of life, treatment adherence and surgical outcomes. In this article, Prof. Baudouin offers straightforward steps to assess OSD and identify the patients most at risk.

What should the ophthalmologist do?

2. Is OSD easily spotted?

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
Related Content
The Intercil Uveal Spacer from Ciliatech, which recently obtained a CE mark, does not penetrate the anterior of the eye. All images courtesy of Ciliatech.

Ciliatech leadership comments on CE mark for novel glaucoma device

Hattie Hayes;Kassi Filkins
September 16th 2025
Article
A computer screen with a lit-up brain on it. The computer is in a laboratory. Concept image of AI artificial intelligence use in glaucoma diagnosis and treatment.

Feasibility of artificial intelligence in leading glaucoma care

Lynda Charters
September 16th 2025
Article
A magnifying glass enhances stocks on a chart. Concept image for global commercialisation agreement, pharmaceutical distribution in eastern and western hemispheres, Europe and EMEA. Image credit: ©Asma – stock.adobe.com

Nicox and Kowa enter commercialisation agreement for NCX 470 glaucoma eye drop

Martin David Harp
September 16th 2025
Article
A close up of an eye with a brown iris, concept image for diabetic retinopathy and glaucoma research. Image credit: ©Made in Uruguay from Pexels – Canva.com

Perfuse Therapeutics shares findings from glaucoma and diabetic retinopathy trials of PER-001

Sydney M Crago
September 16th 2025
Article
A binder labeled "2025 protocol" sits on a pile of papers, graphs and information. Concept image for glaucoma consensus group and interventional glaucoma research findings. Image credit: ©sasirin pamai via Canva.

A new set of guidelines for implementing interventional glaucoma

Hattie Hayes
September 16th 2025
Article
A small icon pinpoints a particular location on a map. Concept image for article titled "pinpointing a first-line treatment for glaucoma." Ophthalmology article, glaucoma laser treatment concept. Image credit: ©Pavlo Vakhrushev – stock.adobe.com

Pinpointing a first-line treatment for glaucoma

José María Martínez de la Casa, MD
September 16th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.